Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Stock investment

Corona crash: what now?

    • Infectiology
    • News
    • RX
  • 2 minute read

The Corona crisis caused stock indices around the world to plummet more than almost any event before. On average, stock markets fell by 30 percent in just a few weeks. And the economy is not doing well either because of the drastic measures. Leading institutes are forecasting a slump worse than during the financial crisis. So what to do with the block of shares?

Buy or sell – that’s what many investors are asking themselves these days. Will the crisis soon be over and will the economy recover quickly? Or do I lose everything if I leave my money invested in stocks? Although every crisis is different and situations cannot be compared, experts nevertheless recognize patterns in which stock markets process events. Therefore, many do not believe that the Corona crisis will stop the long-term upward trend in the stock market. In fact, the U.S. equity market, which has set the tone worldwide, has remained intact so far. Of course, there are no certainties, but Petra Ahrens of MAIESTAS Vermögensmanagement AG in Cologne believes it is likely that the long-term upward trend will continue. The markets could recover more quickly than generally assumed. Long-term bull markets, characterized by ever higher lows and highs, usually last about 25 years. Since the last bear market ended in the financial crisis nine years ago, things have been looking up. According to the calculations, we still have a few years of bull market ahead of us.

Only a stopover

However, not only trends and statistics, but also moderate valuations suggest that the long-term upswing will not end with the Corona crisis, but will merely be a stopover. Experts therefore advise not to simply throw shares out of the portfolio, but to wait and see. New entrants are advised to split investments into multiple tranches to build equity exposure into the rising market.

Source: “What investors should do now. Corona crash: The swan song of the equity bull market is seduced”, 25.04.2020, A&W Online

 

InFo NEUROLOGY & PSYCHIATRY 2020; 18(3): 48 (published 6.5.20, ahead of print).

Autoren
  • Leoni Burggraf
Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Previous Article
  • Antiseptic wound care

Microenvironment is crucial

  • Congress Reports
  • Dermatology and venereology
  • Infectiology
  • RX
View Post
Next Article
  • Diabetes Cases

Prevention of cardiovascular events in type 2 diabetes.

  • Cardiology
  • Endocrinology and Diabetology
  • Partner Content
  • RX
View Post
You May Also Like
View Post
  • 12 min
  • Baxdrostat – a new class of drugs for treating difficult-to-control hypertension

First Aldosterone Synthase Inhibitor Is Here

    • RX
    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Studies
View Post
  • 3 min
  • Geriatric Small-Cell Lung Cancer

Therapeutic Challenges

    • RX
    • Education
    • Geriatrics
    • Oncology
    • Pneumology
    • Studies
View Post
  • 8 min
  • Chronic Pruritus in Renal, Hepatic, and Biliary Tract Diseases

Pooled Expertise for Targeted Evaluation and Treatment

    • RX
    • Dermatology and venereology
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nephrology
    • Studies
View Post
  • 6 min
  • Advanced Thyroid Cancer

Molecular Mechanisms and New Therapeutic Approaches

    • RX
    • Education
    • Endocrinology and Diabetology
    • Oncology
View Post
  • 4 min
  • Epidermolysis bullosa

Promoting Wound Healing with Gene Therapies and Birch Bark Extract

    • RX
    • Dermatology and venereology
    • Education
    • Genetics
    • Pediatrics
    • Pharmacology and toxicology
    • Phytotherapy
    • Studies
View Post
  • 18 min
  • From Risk Identification to Anti-Inflammatory Intervention

Inflammation as a Treatment Goal in Its Own Right

    • RX
    • Angiology
    • Cardiology
    • CME continuing education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • Studies
View Post
  • 3 min
  • Psoriasis Research: What's in the Pipeline?

Highly selective oral TYK inhibitors in Phase III

    • RX
    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • Rheumatology
    • Studies
View Post
  • 11 min
  • Cardiometabolism

Retatrutid and the TRIUMPH Program: The Triple Agonist on the Horizon

    • RX
    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • Prevention and health care
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.